
WHO: 70 COVID-19 Vaccines in Progress, U.S. Moderna and Inovio Are Among Leaders
Three of the COVID-19 vaccine developers have already entered the stage of human trials. These are CanSino, Inovio Pharmaceuticals, and Moderna. Other 67 potential COVID-19 vaccines are still in preclinical evaluation.